Affymetrix Inc. finished clearing away the underbrush of its patent dispute with Oxford Gene Technology Ltd., announcing late Friday that it had settled all pending litigation with the U.K. company. The companies dropped lawsuits in the U.S. and U.K. as well as patent interference proceedings in Europe, leaving AFFX with a license to Oxford Gene's technology.

Oxford Gene (Oxford, U.K.) had been claiming that its array intellectual property, including U.S. Patent No. 5,700,637, were infringed by AFFX's DNA microarray products